Search for: "Eli Lilly and Company " Results 181 - 200 of 1,165
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Dec 2014, 11:24 am by Robert Kreisman
A U.S. district court judge has rejected the attempts of Takeda Pharmaceutical Co. and Eli Lilly & Co. to overturn the combined $9 billion punitive-damage award that a jury recently returned. [read post]
27 Oct 2014, 2:00 pm by Tom Lamb
As a result of this situation, lawsuits have been filed against Eli Lilly by some patients alleging Cymbalta caused withdrawal reactions and injuries when they discontinued or attempted to stop using Cymbalta. [read post]
25 Apr 2014, 8:17 am by Joshua L. Firth
  The jury found that Takeda was 75% liable and Eli Lilly was 25% liable, and split the punitive award accordingly – $6 billion against Takeda and $3 billion against Lilly. [read post]
29 Nov 2021, 1:55 pm by Tom Lamb
Not surprisingly, the pharmaceutical companies AbbieVie and Eli Lilly have attempted to distinguish the safety profile of their respective JAK inhibitors drug product from the various adverse drug reactions that have been observed in the Xeljanz clinical trial referenced by the FDA, above. [read post]
1 Mar 2011, 6:05 pm by Mark Zamora
The Attorney General of Texas has asked drug makers Takeda Pharmaceutical Co. and Eli Lilly & Co. to produce documents as part of an investigation related to the diabetes drug Actos, the companies has informed this week. [read post]
29 Apr 2007, 12:05 am
The FDA is looking into whether Eli Lilly & Company, a pharmaceutical company, provided it with accurate data about the side effects of the antipsychotic drug Zyprexa. [read post]
7 Dec 2009, 6:00 am by Joe Tort
On December 1, 2009 Judge Weinstein issued a ruling granting partial summary judgment to the pharma company Eli Lilly in the lawsuit by the state of Mississippi concerning Zyprexia. [read post]
6 Dec 2009, 9:55 pm
While most of these companies have taken positions supportive of Lilly on the question of the existence of a separate written description requirement, one company (Novozymes) supports Ariad's position and another... [read post]
23 Mar 2007, 3:21 pm
Most recently was this entry from Feb. 14th, 2007 on the 78-page ED NY decision , holding that, to quote the NY Times, "confidential marketing materials belonging to Eli Lilly & Company about its top-selling anti-psychotic drug Zyprexa must be returned to the company by a doctor and a lawyer who, the judge said, engaged in a scheme to leak them to the news media. [read post]
6 Jul 2008, 6:15 am
The IPKat can now reveal that leave to appeal to the House of Lords has been refused in Eli Lilly and Company and others v 8PM Chemist Limited. [read post]
8 Oct 2009, 6:08 am by Brian A. Comer
The action brought by Attorney General Henry McMaster against drug manufacturer Eli Lilly has reportedly settled. [read post]
14 Jan 2007, 1:36 pm
On 12.21.06 the NYT reported (as was noted here): For at least a year, Eli Lilly provided information to doctors about the blood-sugar risks of its drug Zyprexa that did not match data that the company circulated internally when it first reviewed its clinical trial results, according to company documents. [read post]
4 Nov 2011, 9:58 am
., a biopharmaceutical company that uses human DNA sequences to develop protein and antibody drugs, recently received a ruling in its favor by the British Supreme Court in a patent dispute with Eli Lilly & Co. [read post]
28 Apr 2011, 1:40 pm by Lawrence B. Ebert
The court order in SD Ind requires that the remaining defendants not make generic Cymbalta during the patent term and that they tell the FDA that they are no longer seeking approval for a generic duloxetine product during the patent term. [read post]
10 May 2009, 8:50 pm
In yet another chapter in Eli Lilly's Zyprexa saga, the drug company has agreed to pay the State of Georgia a settlement of $6 million. [read post]
27 Dec 2006, 5:28 am
In addition to "playing down" the health risks associated with its Zyprexa drug, Eli Lilly also promoted unapproved use of the drug to physicians. [read post]